Department of Anaesthesiology and Critical Care, AIIMS, Jodhpur, India.
Department of Anaesthesiology and Critical Care, AIIMS, Jodhpur, India.
J Clin Anesth. 2021 Sep;72:110313. doi: 10.1016/j.jclinane.2021.110313. Epub 2021 Apr 24.
To assess whether sequential (one after the other with a delay of 120 s) or combined (freshly prepared mixture) administration of 2% lidocaine and 0.5% bupivacaine in supraclavicular brachial plexus block (SCBPB) provides faster onset and prolonged duration of block.
Randomised controlled double blinded study.
Single centre study in an operating theatre of a tertiary care facility between November 2018 and May 2020.
Ninety-seven patients of either sex, aged between 18 and 65 years, belonging to ASA I to III and undergoing surgery suitable to be performed under SCBPB were enrolled.
Ultrasound guided SCBPB was performed with 20 mL of freshly prepared mixture of 2% lidocaine and 0.5% bupivacaine (10 mL each) in group C (combined) and 10 mL 2% lidocaine followed 120 s later by 10 mL 0.5% bupivacaine in group S (sequential).
Time to onset of complete sensory block was the primary outcome while time to onset of first sensory block and complete motor block, duration of sensory and motor block, duration of analgesia, use of intraoperative supplement, rescue analgesic consumption, and pain scores at rest and with movement were secondary outcomes.
There was no significant difference between group C and group S in time to onset of complete sensory block [median (IQR) 16 (11, 20.5) and 15.5 (13, 21.75) minutes respectively] (p-value 0.58). The time to onset of first sensory block and motor block, duration of sensory and motor block, duration of analgesia, use of intraoperative supplement, postoperative pain scores and rescue analgesic requirement were also similar (p-value >0.05).
There was no advantage of sequential administration of 2% lidocaine and 0.5% bupivacaine over the administration of combination of both LAs in terms of onset and duration of block.
评估在锁骨上臂丛阻滞(SCBPB)中序贯(间隔 120 秒依次给予)或联合(新鲜配制的混合物)给予 2%利多卡因和 0.5%布比卡因给药方式,哪种方式能更快起效并延长阻滞持续时间。
随机对照双盲研究。
2018 年 11 月至 2020 年 5 月在一家三级医疗机构的手术室进行的单中心研究。
97 例性别不限、年龄 18-65 岁、ASA 分级 I-III 级、拟行 SCBPB 手术的患者入选。
超声引导下 SCBPB,在 C 组(联合组)中给予 20ml 新鲜配制的 2%利多卡因和 0.5%布比卡因混合物(各 10ml),在 S 组(序贯组)中先给予 10ml 2%利多卡因,间隔 120 秒后再给予 10ml 0.5%布比卡因。
完全感觉阻滞起效时间为主要结局,首次感觉阻滞起效时间和完全运动阻滞起效时间、感觉和运动阻滞持续时间、镇痛持续时间、术中追加药物使用、补救性镇痛药物消耗、静息和运动时疼痛评分均为次要结局。
完全感觉阻滞起效时间在 C 组和 S 组之间无显著差异[中位数(IQR)分别为 16(11,20.5)和 15.5(13,21.75)分钟](p 值=0.58)。首次感觉阻滞和运动阻滞起效时间、感觉和运动阻滞持续时间、镇痛持续时间、术中追加药物使用、术后疼痛评分和补救性镇痛药物需求也相似(p 值>0.05)。
在起效时间和阻滞持续时间方面,2%利多卡因和 0.5%布比卡因序贯给药与两种局麻药联合应用相比没有优势。